120 related articles for article (PubMed ID: 76512)
1. Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases.
Gormley PE; Sethi VS; Cysyk RL
Cancer Res; 1978 May; 38(5):1300-6. PubMed ID: 76512
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
[TBL] [Abstract][Full Text] [Related]
3. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids.
Wilson WR; Baguley BC; Wakelin LP; Waring MJ
Mol Pharmacol; 1981 Sep; 20(2):404-14. PubMed ID: 6170872
[No Abstract] [Full Text] [Related]
5. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells.
Zwelling LA; Kerrigan D; Marton LJ
Cancer Res; 1985 Mar; 45(3):1122-6. PubMed ID: 2982483
[TBL] [Abstract][Full Text] [Related]
6. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
Adlakha RC; Ashorn CL; Chan D; Zwelling LA
Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
[TBL] [Abstract][Full Text] [Related]
7. The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats.
Cysyk RL; Shoemaker D; Adamson RH
Drug Metab Dispos; 1977; 5(6):579-90. PubMed ID: 21782
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
[TBL] [Abstract][Full Text] [Related]
9. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
Pierson V; Pierre A; Pommier Y; Gros P
Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mammalian and oncornavirus nucleic acid polymerase activities by alkoxybenzophenanthridine alkaloids.
Sethi VS
Cancer Res; 1976 Jul; 36(7 PT 1):2390-5. PubMed ID: 58719
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
Zwelling LA; Kerrigan D; Michaels S
Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.
Hudecz F; Kajtár J; Szekerke M
Nucleic Acids Res; 1981 Dec; 9(24):6959-73. PubMed ID: 6174949
[TBL] [Abstract][Full Text] [Related]
13. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
Jensen PB; Sørensen BS; Demant EJ; Sehested M; Jensen PS; Vindeløv L; Hansen HH
Cancer Res; 1990 Jun; 50(11):3311-6. PubMed ID: 2159380
[TBL] [Abstract][Full Text] [Related]
15. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
Wilson WR; Whitmore GF; Hill RP
Cancer Res; 1981 Jul; 41(7):2817-22. PubMed ID: 7018670
[TBL] [Abstract][Full Text] [Related]
16. Base specificity in the inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases by antitumor drugs.
Sethi VS
Ann N Y Acad Sci; 1977 Mar; 284():508-24. PubMed ID: 81641
[TBL] [Abstract][Full Text] [Related]
17. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
Rowe TC; Chen GL; Hsiang YH; Liu LF
Cancer Res; 1986 Apr; 46(4 Pt 2):2021-6. PubMed ID: 3004716
[TBL] [Abstract][Full Text] [Related]
18. Oral absorption and selective tissue localization of 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
Cysyk RL; Shoemaker DD; Ayers OC; Adamson RH
Pharmacology; 1978; 16(4):206-13. PubMed ID: 204947
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule.
Van Echo DA; Chiuten DF; Gormley PE; Lichtenfeld JL; Scoltock M; Wiernik PH
Cancer Res; 1979 Oct; 39(10):3881-4. PubMed ID: 476624
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes.
Shoemaker DD; Cysyk RL; Gormley PE; DeSouza JJ; Malspeis L
Cancer Res; 1984 May; 44(5):1939-45. PubMed ID: 6546898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]